Early is Good Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 2

Early is Good General Information

Description

Provider of cancer research and molecular biomarkers services intended to help refer to substances that indicate the presence of cancer in the body. The company specializes in non-subjective BC diagnostic tests that can distinguish healthy and oncogenic cells earlier and more specifically than a cystoscopy and more, enabling patients with a biomarker-based approach to get early, accurate, and widely accessible detection of diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1210 Waterway Boulevard
  • Suite 2000
  • Indianapolis, IN 46202
  • United States
+1 (317)
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Pharmaceuticals
Biotechnology
Corporate Office
  • 1210 Waterway Boulevard
  • Suite 2000
  • Indianapolis, IN 46202
  • United States
+1 (317)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Early is Good Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Accelerator/Incubator Completed Generating Revenue
3. Early Stage VC (Series 2) 02-Nov-2022 Completed Generating Revenue
2. Seed Round $400K $1.9M Completed Generating Revenue
1. Debt - General 02-Nov-2022 $1.5M $1.5M Completed Generating Revenue
To view Early is Good’s complete valuation and funding history, request access »

Early is Good Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed 2
Seed
To view Early is Good’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Early is Good Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider of cancer research and molecular biomarkers services intended to help refer to substances that indicate the pre
Laboratory Services (Healthcare)
Indianapolis, IN
4 As of 2024

Houston, TX
 

Salt Lake City, UT
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Early is Good Competitors (7)

One of Early is Good’s 7 competitors is SpectraCell Laboratories, a Formerly PE-Backed company based in Houston, TX.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
SpectraCell Laboratories Formerly PE-Backed Houston, TX
BioFire Venture Capital-Backed Salt Lake City, UT
ARUP Laboratories Corporation Salt Lake City, UT
Myriad Genetics Corporation Salt Lake City, UT
InCellDx Venture Capital-Backed Hayward, CA
You’re viewing 5 of 7 competitors. Get the full list »

Early is Good Patents

Early is Good Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2024404206-A1 Multi-omic integration platform Pending 20-Dec-2023
EP-4829502-A1 Multi-omic integration platform Pending 20-Dec-2023
US-20250208123-A1 Multi-omic integration platform Pending 20-Dec-2023
WO-2025137399-A1 Multi-omic integration platform Inactive 20-Dec-2023
US-20240307867-A1 Fiber arrays Pending 24-Feb-2023 G01N33/54346
To view Early is Good’s complete patent history, request access »

Early is Good Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Early is Good Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Social Capital Venture Capital Minority
Indiana Center for Biomedical Innovation Accelerator/Incubator
To view Early is Good’s complete investors history, request access »

Early is Good FAQs

  • When was Early is Good founded?

    Early is Good was founded in 2020.

  • Where is Early is Good headquartered?

    Early is Good is headquartered in Indianapolis, IN.

  • What is the size of Early is Good?

    Early is Good has 4 total employees.

  • What industry is Early is Good in?

    Early is Good’s primary industry is Laboratory Services (Healthcare).

  • Is Early is Good a private or public company?

    Early is Good is a Private company.

  • What is Early is Good’s current revenue?

    The current revenue for Early is Good is .

  • How much funding has Early is Good raised over time?

    Early is Good has raised $5.9M.

  • Who are Early is Good’s investors?

    Social Capital and Indiana Center for Biomedical Innovation have invested in Early is Good.

  • Who are Early is Good’s competitors?

    SpectraCell Laboratories, BioFire, ARUP Laboratories, Myriad Genetics, and InCellDx are some of the 7 competitors of Early is Good.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process